PortfoliosLab logoPortfoliosLab logo
SPMO vs. UTHR
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SPMO vs. UTHR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P 500 Momentum ETF (SPMO) and United Therapeutics Corporation (UTHR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SPMO achieves a 21.07% return, which is significantly higher than UTHR's 6.25% return. Over the past 10 years, SPMO has outperformed UTHR with an annualized return of 19.57%, while UTHR has yielded a comparatively lower 15.19% annualized return.


SPMO

1D
0.29%
1M
-7.40%
6M
20.51%
YTD
21.07%
1Y
25.37%
3Y*
37.36%
5Y*
20.21%
10Y*
19.57%
ALL TIME*
18.93%

UTHR

1D
-1.54%
1M
-5.38%
6M
10.27%
YTD
6.25%
1Y
88.46%
3Y*
29.19%
5Y*
23.26%
10Y*
15.19%
ALL TIME*
17.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$331.54M$346.70M$350.59M
$217.22M$211.82M$269.54M

SPMO vs. UTHR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SPMO
Invesco S&P 500 Momentum ETF
21.07%26.58%45.82%17.56%-10.45%22.64%28.25%25.93%-0.92%27.76%
UTHR
United Therapeutics Corporation
6.25%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%

Correlation

The correlation between SPMO and UTHR is 0.01, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.01

Correlation (3Y)
Balances recent behavior with more history.

0.12

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.21

Correlation (10Y)
Provides a long-term view across more market conditions.

0.24

Correlation (All Time)
Calculated using the full available price history since Oct 12, 2015

0.22

Over the past year, the correlation between SPMO and UTHR has dropped to 0.01 - well below their long-term average of 0.22, suggesting their price drivers have been diverging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SPMO vs. UTHR — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

SPMO
SPMO Risk / Return Rank: 4646
Overall Rank
SPMO Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
SPMO Sortino Ratio Rank: 4343
Sortino Ratio Rank
SPMO Omega Ratio Rank: 4545
Omega Ratio Rank
SPMO Calmar Ratio Rank: 4646
Calmar Ratio Rank
SPMO Martin Ratio Rank: 5151
Martin Ratio Rank

UTHR
UTHR Risk / Return Rank: 9595
Overall Rank
UTHR Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9898
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9696
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

SPMO vs. UTHR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500 Momentum ETF (SPMO) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SPMOUTHRDifference
Sharpe ratioReturn per unit of total volatility

-0.82

Sortino ratioReturn per unit of downside risk

-2.77

Omega ratioGain probability vs. loss probability

1.21

1.49

-0.29

Calmar ratioReturn relative to maximum drawdown

1.63

6.71

-5.09

Martin ratioReturn relative to average drawdown

5.93

15.67

-9.74

SPMO vs. UTHR - Sharpe Ratio Comparison

The current SPMO Sharpe Ratio is 1.07, which is lower than the UTHR Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of SPMO and UTHR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SPMO vs. UTHR - Drawdown Comparison

The maximum SPMO drawdown since its inception was -30.95%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for SPMO and UTHR.


Loading charts...

Drawdown Indicators


SPMOUTHRDifference

Max Drawdown

Largest peak-to-trough decline

-30.95%

-93.18%

+62.23%

Max Drawdown (1Y)

Largest decline over 1 year

-15.64%

-13.25%

-2.39%

Max Drawdown (3Y)

Largest decline over 3 years

-20.13%

-33.00%

+12.87%

Max Drawdown (5Y)

Largest decline over 5 years

-22.74%

-33.00%

+10.26%

Max Drawdown (10Y)

Largest decline over 10 years

-30.95%

-55.56%

+24.61%

Current Drawdown

Current decline from peak

-11.03%

-13.25%

+2.22%

Average Drawdown

Average peak-to-trough decline

-4.62%

-35.18%

+30.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.29%

5.66%

-1.37%

Volatility

SPMO vs. UTHR - Volatility Comparison

Invesco S&P 500 Momentum ETF (SPMO) has a higher volatility of 10.53% compared to United Therapeutics Corporation (UTHR) at 6.09%. This indicates that SPMO's price experiences larger fluctuations and is considered to be riskier than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SPMOUTHRDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.53%

6.09%

+4.44%

Volatility (6M)

Calculated over the trailing 6-month period

21.52%

25.86%

-4.34%

Volatility (1Y)

Calculated over the trailing 1-year period

23.90%

47.15%

-23.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.60%

35.05%

-14.45%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

20.92%

34.89%

-13.97%

Dividends

SPMO vs. UTHR - Dividend Comparison

SPMO's dividend yield for the trailing twelve months is around 0.73%, while UTHR has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
SPMO
Invesco S&P 500 Momentum ETF
0.73%0.73%0.48%1.63%1.66%0.52%1.27%1.39%1.05%0.77%1.94%0.36%
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


SPMO and UTHR have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SPMO has higher volatility (10.53%) compared to UTHR (6.09%). In terms of maximum drawdown, SPMO dropped -30.95% vs UTHR's -93.18%.

UTHR currently has the higher Sharpe Ratio (1.89 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SPMO and UTHR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer